Treatment of cutaneous Leishmaniasis (old world)

Clinics in Dermatology

Volumn 14, Issue 5, 1996, Pages 513-517

  Dowlati, Yahya ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTILEISHMANIAL AGENT; DAPSONE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; MEGLUMINE ANTIMONATE; METHYLBENZETHONIUM CHLORIDE; PENTAMIDINE; STIBOGLUCONATE SODIUM;

ANTIBIOTIC THERAPY; CRYOTHERAPY; CURETTAGE; HUMAN; HYPERTHERMIC THERAPY; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; SKIN LEISHMANIASIS; TRADITIONAL MEDICINE;

EID: 0030248704     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0738-081X(96)00047-8     Document Type: Article

References (28)

1. 1. Currie MA. Treatment of cutaneous leishmaniases by curretage. Br Med J 1983;287:1083.
2. 2. Kurban AK, Farah FS, Chaglassian HT. The treatment of cutaneous leishmaniases. Dermatol Int 1967;6:168-71.
3. 3. Rahim GF, Tatar TH. Oriental sore in Iraq. Bull Endem Dis 1966;8:29-54.
4. 4. Dostrovisky A, Sagher F. Treatment of cutaneous leishmaniases by Grenz ray. Arch Dermatol Syphilol 1942;45: 1868-74.
5. 5. Neva FA, Peterson EA, Corsey R, et al. Observation on local heat treatment for cutaneous leishmaniases. Am J Trop Med Hyg 1984;33:8004.
6. 6. Navin TR, Arana BA, Arana FE, et al. Placebo controlled clinical trial of meglumine antimonate vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg 1990;42:43-50.
7. 7. Bassouny A, El Meshad M, Talaat M, et al. Cryosurgery in cutaneous leishmaniasis. Br J Dermatol 1982;107:467-74.
8. 8. WHO Technical Report Series 793, 1990.
9. 9. Kellum RE. Treatment of cutaneous leishmaniases with an interalesional drug (Pentostam). J Am Acad Dermatol 1986;15:620.
10. 10. Marinkelle C. The control of leishmaniasis. Bull WHO 1980;58:807-18.
11. 11. El-On J, Livshin R, Evans-Paz Z, et al. Topical treatment of cutaneous leishmaniases. Br Med J 1985;291:1280-1.
12. 12. Neax RA, Murphy AG, Olliaro P, et al. Aminosidine ointment for the treatment of experimental cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1994;88:223-5.
13. 13. Asilian A, Talayer T, Whitworth JAG, et al. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg 1995;53: 648-52.
14. 14. Das N, Mahato SB, Naskar K, et al. Targeting of urea stibamine encapsulated in liposomes to reticuloendothelial system for the treatment of experimental leishmaniasis. Biochem Med Metab Biol 1990;43:133-9.
15. 15. Dogra J. A double blind study on the efficacy of oral dapson in cutaneous leishmaniases. Trans R Soc Trop Med Hyg 1991;85:212-3.
16. 16. Marr JJ, Berens RL. Pyrazolopyrimidine metabolism in the pathogenic tyrpanosomatidae. Mol Biochem Parasitol 1983;7:339-56.
17. 17. Berens RL, Marr JJ, Nelson DJ, et al. Antileishmanial effect of allopurinol and allopurinol ribonucleoside on intracellular forms of Leishmania donovani. Biochem Pharmacol 1980;29:2397-8.
18. 18. Marr JJ, Berens RL, Nelson DJ, et al. Antileishmanial action of 4-thiopyrazolo (3.4-d) pyrimidine and its ribonucleoside. Biochem Pharmacol 1982;31:143-8.
19. 19. Lafon SW, Nelson DJ, Berens RL, et al. Inosine analogs: Their metabolism in mouse cells and in Leishmania donovani. J Biol Chem 1985;260:9660-5.
20. 20. Martinez S, Looker DL, Berens RL, et al. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis. Am J Trop Med Hyg 1988;39:250-5.
21. 21. Sanez RE, Paz HM, Johnson CM, et al. Treatment of American cutaneous leishmaniasis with orally administered allopurinol riboside. J Infect Dis 1989;160:153-8.
22. 22. Martinez S, Marr JJ. Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med 1992; 326(11):741-4.
23. 23. Momeni AZ, Aminjavaheri M. Treatment of recurrent cutaneous leishmaniasis. Int J Dermatol 1995;34:129-33.
24. 24. Navin TR, Arana BR, Berman JD, et al. Placebo-controlled clinical trial of stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniases in Guatemala. J Infect Dis 1992;165:528-34.
25. 25. Convit J, Rondon A, Ulrich M. Immunotherapy versus chemotherapy in localized cutaneaous leishmaniases. Lancet 1987;21:401-4.
26. 26. Convit J, Castellanos P, Ulrich M, et al. Immunotherapy of localized, intermediate, and diffuse forms of American cutaneaous leishmaniases. J Infect Dis 1989;160:104-15.
27. 27. Ho GL, Badaro R, Hatzigeorgioud D, et al. Cytokines in the treatment of leishmaniasis: from study of immunopathology to patient therapy. Biotherapy 1994;7:223-35.
28. 28. Harms G, Chehade AK, Racz P, et al. Effects of intradermal gamma-interferon in cutaneous leishmaniases. Lancet 1989;10:1287-92.